|
Market Closed -
Nasdaq
01:30:00 05/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 5.720 USD | +1.42% |
|
+11.94% | -61.56% |
| 14/08 | Seres Therapeutics Files $300 Million Mixed Shelf | MT |
| 05/08 | Seres Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 5.69Cr 4.89Cr 4.6Cr 4.21Cr 7.87Cr 536.89Cr 7.89Cr 54Cr 21Cr 275.46Cr 21Cr 21Cr 887.4Cr | P/E 2026 * |
-1.63x | P/E 2027 * | -1.16x |
|---|---|---|---|---|---|
| Enterprise Value | 5.69Cr 4.89Cr 4.6Cr 4.21Cr 7.87Cr 536.89Cr 7.89Cr 54Cr 21Cr 275.46Cr 21Cr 21Cr 887.4Cr | EV / Sales 2026 * |
4.12x | EV / Sales 2027 * | 208x |
| Free-Float |
88.51% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MCRB | Delayed | |
CBOE
| MCRB | Real-time | |
|
Deutsche Boerse AG
| 1S90 | Delayed | |
|
Börse Stuttgart
| 1S90 | Delayed | |
|
Tradegate
| 1S90 | Real-time | |
|
Boerse Muenchen
| 1S90 | Real-time |
Last Transcript : Seres Therapeutics, Inc.
| 1 day | +1.42% | ||
| 1 week | +11.94% | ||
| Current month | +16.50% | ||
| 1 month | +8.95% | ||
| 3 months | -16.50% | ||
| 6 months | -37.35% | ||
| Current year | -61.56% |
| 1 week | 4.91 |  | 5.95 |
| 1 month | 4.32 | | 5.95 |
| Current year | 4.32 | | 16.42 |
| 1 year | 4.32 | | 29.98 |
| 3 years | 4.32 | | 70.4 |
| 5 years | 4.32 | | 233.8 |
| 10 years | 4.32 | | 770 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Kender
CEO | Chief Executive Officer | 70 | 02/03/2026 |
Ann Thorell
CEO | Chief Executive Officer | 58 | 01/08/2025 |
Matthew Henn
PSD | President | 51 | 02/03/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Richard Kender
CHM | Chairman | 70 | 02/03/2026 |
Eric Shaff
BRD | Director/Board Member | 50 | 15/01/2019 |
Dennis Ausiello
BRD | Director/Board Member | 80 | 01/04/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 17/08/26 | Sell | General Counsel | -82 | 0.0008% | ||
| 17/08/26 | Sell | Director | -263 | 0.0027% | ||
| 17/08/26 | Sell | Chief Operating Officer | -64 | 0.0007% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.42% | +11.94% | -69.57% | -92.12% | 5.69Cr | |
| -1.79% | -2.27% | +50.90% | +89.03% | 6.8TCr | |
| -2.06% | -0.18% | +41.53% | +88.17% | 6.49TCr | |
| -0.31% | +6.54% | -11.39% | +457.82% | 2.76TCr | |
| -3.00% | -2.90% | +39.40% | +9.41% | 2.57TCr | |
| +0.86% | +1.65% | +0.25% | -14.78% | 2.61TCr | |
| -1.46% | +0.42% | +24.07% | -18.70% | 2.01TCr | |
| -2.96% | -15.21% | +210.71% | +370.84% | 1.72TCr | |
| -1.49% | -4.88% | -0.41% | +530.26% | 1.49TCr | |
| -0.20% | +8.37% | +57.87% | +159.50% | 1.46TCr | |
| Average | -1.10% | +1.43% | +34.34% | +157.94% | 2.79TCr | |
| Weighted average by Cap. | -1.52% | +0.18% | +42.27% | +145.03% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.38Cr 1.19Cr 1.12Cr 1.02Cr 1.91Cr 130.27Cr 1.91Cr 13Cr 5.12Cr 67Cr 5.18Cr 5.07Cr 215.31Cr | 3L 2L 2L 2L 4L 2.58Cr 4L 26.17L 10.15L 1.32Cr 10.27L 10.05L 4.27Cr |
| Net income | -3.75Cr -3.23Cr -3.04Cr -2.77Cr -5.19Cr -353.95Cr -5.2Cr -36Cr -14Cr -181.6Cr -14Cr -14Cr -585.03Cr | -7.9Cr -6.79Cr -6.39Cr -5.84Cr -11Cr -745.46Cr -11Cr -76Cr -29Cr -382.47Cr -30Cr -29Cr -1.23TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/26/04 | $5.720 | +1.42% | 36,447 |
| 03/26/03 | $5.640 | +1.81% | 1,35,979 |
| 02/26/02 | $5.540 | +6.95% | 63,655 |
| 01/26/01 | $5.180 | +5.50% | 49,169 |
| 31/26/31 | $4.910 | -3.91% | 44,226 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MCRB Stock
Select your edition
All financial news and data tailored to specific country editions
